Business News • PR NewsWire • New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB

New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB

New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB

STOCKHOLM, May 17, 2018 /PRNewswire/ -- The EFECT-study evaluated standard hormonal therapies for women with advanced breast cancer and DiviTum® was used as a non-invasive tool for monitoring therapy response. 244 patients had blood samples analyzed with DiviTum® in a collaboration...

View More : https://www.prnewswire.com/news-releases/new-study-results-presented-at-asco-supports-divitum-for-monitoring-advanced-br...

Releted News by prnewswire

La région de La Mecque en Arabie saoudite accélère ses plans de développement avec des opportunités d'investissement d'une valeur de plus de 280 millions USD

iQIYI 2018 World Conference Showcases Thriving Entertainment Ecosystem